Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Hydroxychloroquine  COVID-19 treatment studies for HCQ  C19 studies: HCQ  HCQ   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxychloroquine and azithromycin in Lebanon
Chamieh et al., medRxiv 2020.05.28.20114835, doi:10.1101/2020.05.28.20114835 (Preprint)
Chamieh et al., Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxychloroquine and.., medRxiv 2020.05.28.20114835, doi:10.1101/2020.05.28.20114835 (Preprint)
May 2020   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
HCQ+AZ potentially explains 94.7% success in treating a fairly complex cohort.
Chamieh et al., 28 May 2020, preprint, 10 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperHCQAll
Abstract: medRxiv preprint doi: https://doi.org/10.1101/2020.05.28.20114835; this version posted June 2, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . 1 Category : Original Article 2 Title: Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with 3 hydroxychloroquine and azithromycin in Lebanon. 4 5 Authors: 6 Amanda Chamieh1,2, Claude Afif2, Gerard El-Hajj3, Omar Zmerli2, Isabelle Djaffar- 7 Jureidini4, Roy A. Raad3, Raja Ashou3, Georges Juvelekian5, Jean-Marc Rolain1 and Eid 8 Azar2* 9 10 11 Affiliations: 1- Aix-Marseille Université, AP-HM, Institut de Recherche pour le Développement 12 (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Institut Hospitalo- 13 Universitaire Méditerranée-Infection, Marseille, France. 14 15 16 17 18 19 20 21 2- Division of Infectious Diseases, Saint George Hospital University Medical Center, Beirut, Lebanon. 3- Department of Radiology, Saint George Hospital University Medical Center, Beirut, Lebanon. 4- Department of Laboratory Medicine, Saint George Hospital University Medical Center, Beirut, Lebanon. 5- Department of Pulmonary and Critical Care Medicine, Saint George Hospital University Medical Center, Beirut, Lebanon. 22 23 Running Title: Viral Dynamics Matter in COVID-19 Pneumonia 24 25 Declarations of Interest and Funding/Support Statement: 3 NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.05.28.20114835; this version posted June 2, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . 26 This research did not receive any specific grant from funding agencies in the public, 27 commercial, or not-for-profit sectors. 28 Acknowledgements: 29 This work was supported by the Saint George Hospital University Medical Center 30 Beirut, Lebanon. 31 *Corresponding Author: 32 Eid Azar, M.D. 33 Infectious Disease, Chief of Staff 34 Associate Chief Medical Officer for Safety, Risk Management, and Infection Prevention and 35 Control 36 Saint George Hospital University Medical Center, Youssef Sursock St. – Achrafieh, Beirut, 37 Lebanon; eeazar@stgeorgehospital.org; +961 03 665358 38 39 40 4 medRxiv preprint doi: https://doi.org/10.1101/2020.05.28.20114835; this version posted June 2, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . 41 Category: Original Article 42 43 Title: Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with 44 hydroxychloroquine and azithromycin in Lebanon. 45 46 Running Title: Viral Dynamics Matter in COVID-19 Pneumonia 5 medRxiv preprint doi: https://doi.org/10.1101/2020.05.28.20114835; this version posted June 2, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to..
Late treatment
is less effective
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit